Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids.
about
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Adeno-associated viral vectors for the treatment of hemophilia.Adeno-Associated Virus: The Naturally Occurring Virus Versus the Recombinant Vector.Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectorsSuperior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid.Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistanceLow-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction.In vivo tissue-tropism of adeno-associated viral vectors.State of the art: gene therapy of haemophilia.Systemic delivery of adeno-associated viral vectors.Potential for cellular stress response to hepatic factor VIII expression from AAV vectorCRISPR/Cas9: at the cutting edge of hepatology.Selecting the Best AAV Capsid for Human Studies.Delivering efficient liver-directed AAV-mediated gene therapy.Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity.The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice.Gene Therapy for Hemophilia.Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver.Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse.Lessons learned from lung and liver in-vivo gene therapy: implications for the future
P2860
Q33881920-861DD5A4-8D77-406D-9359-FDD75D6B0BC6Q36713767-44DDDDF0-6C05-4370-B081-B1D7D878EBC8Q36732799-5143BBC6-2599-4E80-9481-4B4F02BB1906Q36867801-69ABFB5C-4D87-43D4-B7E4-6A96CEBBA09CQ37043507-C66975EA-59B2-4B28-AF78-AAE759BDF6A7Q37652049-F2BD60A6-A59C-444B-9C5B-9DE7D9A5DFE9Q37717893-894E292A-74B5-43BB-88BC-AC74F50FEFFCQ38824171-2655514A-83B1-4778-A2A3-629E84175591Q38894169-4D808721-3E01-4B65-9AED-2D689C866BCDQ38908933-40DA67A1-906C-4EE0-8AA9-B4AE9E28005CQ39293496-E6E814A4-908A-411D-848B-6FF3AE8D3911Q39294371-50268680-2DB1-4792-8720-A9C012C6B5A6Q42671274-D74668E7-6C21-4A8D-82B3-6907ECEC8B1EQ45863544-D081B5F2-49EE-4969-BB3F-2F8D95120DBFQ45873427-6CB82424-F290-45C9-BDBF-7D89A9D10F39Q50083826-D3D0E21B-7DC1-4AC7-8942-EDAD37C229E7Q51057724-A9A4369D-BF01-4A8D-9514-0A24E3E6D342Q54241222-68957E5C-16A4-4DC2-B4E2-2A58B2E668F7Q55471442-86113EB4-246C-4046-AB89-C19C804D9A3BQ57163666-6451124F-C126-4B53-9FC2-E8643E4CC6DA
P2860
Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Comparative Study of Liver Gen ...... al and Engineered AAV Capsids.
@ast
Comparative Study of Liver Gen ...... al and Engineered AAV Capsids.
@en
type
label
Comparative Study of Liver Gen ...... al and Engineered AAV Capsids.
@ast
Comparative Study of Liver Gen ...... al and Engineered AAV Capsids.
@en
prefLabel
Comparative Study of Liver Gen ...... al and Engineered AAV Capsids.
@ast
Comparative Study of Liver Gen ...... al and Engineered AAV Capsids.
@en
P2093
P2860
P356
P1433
P1476
Comparative Study of Liver Gen ...... ral and Engineered AAV Capsids
@en
P2093
Deirdre McMenamin
Hongwei Yu
Peter Bell
Qiang Wang
Roberto Calcedo
Suryanarayan Somanathan
Tamara Goode
Zhenning He
P2860
P304
P356
10.1038/MT.2015.179
P577
2015-09-28T00:00:00Z